Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation
European Journal of Pharmaceutics and Biopharmaceutics · 2025
DOI: 10.1016/j.ejpb.2024.114589 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Camila Machado França de Almeida und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: mfrancacamila@usp.br. Hauptthemen laut MEDLINE: Apoferritins, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: State of Sao Paulo Research Foundation, National Council for Scientific and Technological Development, Coordination of Higher Education Personnel Improvement.
Abstract (Originalsprache)
Apoferritin-based systems have been explored last decade for their potential as vaccine delivery for viral diseases. The nanosized properties of an apoferritin-based system could increase immunogenicity, contribute to antigen stability, and reduce the vaccines' adverse effects. The mutated extracellular portion of the epidermal growth factor receptor (EGFRvIII peptide, PEPvIII) can be applied as a specific tumoral antigen due to rare expression in normal cells. In this context, the present study proposed the development and the immunogenicity evaluation of an apoferritin-based system (AFt) to deliver a peptide vaccine for an antitumoral purpose. We developed a formulation with different PEPvIII:AFt ratios and during the association efficiency analysis, identified the dependence between the AFt concentration and the PEPvIII association percentage in the formulation. Besides, differences in the immune responses against EGFRvIII were observed depending on the PEPvIII concentration due to the different association efficiencies. Finally, the humoral immune response results showed a high antibody production against AFt, which might affect the immunological tolerance. Collectively, this study establishes the PEPvIII:AFt formulation process and highlights the determinant factors for guaranteeing vaccine safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: mfrancacamila@usp.br.
- Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: wendy@usp.br.
- School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: maira@fcfrp.usp.br.
- Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: izausp@fmrp.usp.br.
- School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: nataliapaiva@usp.br.
- School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: fabtesta@fcfrp.usp.br.
Förderung
- State of Sao Paulo Research Foundation
- National Council for Scientific and Technological Development
- Coordination of Higher Education Personnel Improvement
Zitieren
APA
de Almeida, C. M. F., Rios, W. M., Duarte, M. P. F., Brandão, I. T., Paiva, N. F., & Vicentini, F. T. M. C. (2025). Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114589
Vancouver
de Almeida CMF, Rios WM, Duarte MPF, Brandão IT, Paiva NF, Vicentini FTMC. Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2024.114589
BibTeX
@article{deAlmeida2025,
author = {de Almeida, Camila Machado França and Rios, Wendy Martin and Duarte, Maíra Peres Ferreira and Brandão, Izaíra Tincani and Paiva, Natalia Floriano and Vicentini, Fabiana Testa Moura de Carvalho},
title = {Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2025},
doi = {10.1016/j.ejpb.2024.114589}
}
EUVIMED